warnings
WARNINGS Flavoxate hydrochloride should be given cautiously in patients with suspected glaucoma.
Flavoxate Hydrochloride
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Flavoxate Hydrochloride
- Generic name
- FLAVOXATE HYDROCHLORIDE
- Manufacturer
- PuraCap Laboratories LLC dba Blu Pharmaceuticals
- Product type
- HUMAN PRESCRIPTION DRUG
- SPL set ID
- f6a06eda-2480-4c0d-8d1e-9e3e89d3ee88
- SPL ID
- cdb3dd6e-969c-4f0c-888b-a3e1b7062fda
- Version
- 6
- Effective date
- 2025-12-11
- Source export date
- 2026-10-12
- Source partition
- 11
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0011-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/a497e765d824a2e2aa9e88d5f0eea2aae9dcba363989e5f163395cda5c3c9dd8/drug-label-0011-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:42:58
| Harmonized routes |
|---|
| ORAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| application applno | ANDA | 076835 | derived:openfda.application_number |
| application number | ANDA076835 | openfda.application_number | |
| brand name | Flavoxate Hydrochloride | openfda.brand_name | |
| generic name | FLAVOXATE HYDROCHLORIDE | openfda.generic_name | |
| manufacturer name | PuraCap Laboratories LLC dba Blu Pharmaceuticals | openfda.manufacturer_name | |
| ndc | package | 24658-720-01 | openfda.package_ndc |
| ndc | product | 24658-720 | openfda.product_ndc |
| ndc11 | package | 24658072001 | derived:openfda.package_ndc |
| rxcui | 1095229 | openfda.rxcui | |
| spl id | cdb3dd6e-969c-4f0c-888b-a3e1b7062fda | id | |
| spl set id | f6a06eda-2480-4c0d-8d1e-9e3e89d3ee88 | set_id | |
| unii | 9C05J6089W | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
adverse reactions
ADVERSE REACTIONS The following adverse reactions have been observed, but there are not enough data to support an estimate of their frequency. Gastrointestinal: Nausea, vomiting, dry mouth. CNS: Vertigo, headache, mental confusion, especially in the elderly, drowsiness, nervousness. Hematologic: Leukopenia (one case which was reversible upon discontinuation of the drug). Cardiovascular: Tachycardia and palpitation. Allergic : Urticaria and other dermatoses, eosinophilia and hyperpyrexia. Ophthalmic: Increased ocular tension, blurred vision, disturbance in eye accommodation. Renal: Dysuria.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.